HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JNM Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kurhanewicz, J. Articles by Vigneron, D. B. Search for Related Content PubMed PubMed Citation Articles by Kurhanewicz, J. Articles by Vigneron, D. B.

Current and Potential Applications of Clinical ¹³C MR Spectroscopy

University of California San Francisco
San Francisco, California

Correspondence: For correspondence or reprints contact: John Kurhanewicz, PhD, UCSF Mission Bay Campus, Byers Hall, Room 203E, 1700 4th St., San Francisco, CA 94158-2330. E-mail: John.Kurhanewicz{at}radiology.ucsf.edu

ABSTRACT

In this article, the current and potential clinical roles of ¹³C magnetic resonance spectroscopy (MRS) and ¹³C magnetic resonance spectroscopic imaging are presented, with a focus on applications to prostate cancer and hyperpolarized ¹³C spectroscopic imaging. The advantages of ¹³C MRS have been its chemical specificity and lack of background signal, with the major disadvantage being its inherently low sensitivity and the subsequent inability to acquire data at a high-enough spatial and temporal resolution to be routinely applicable in the clinic. The approaches to improving the sensitivity of ¹³C spectroscopy have been to perform proton decoupling and to use endogenous ¹³C-labeled or enhanced metabolic substrates. With these nominal increases in signal-to-noise ratio, ¹³C MRS using labeled metabolic substrates has shown diagnostic promise in patients and has been approved by the Food and Drug Administration. The development of technology that applies dynamic nuclear polarization to generate hyperpolarized ¹³C-labeled metabolic substrates, and the development of a process for delivering them into living subjects, have totally changed the clinical potential of MRS of ¹³C-labeled metabolic substrates. Preliminary preclinical studies in a model of prostate cancer have demonstrated the potential clinical utility of hyperpolarized ¹³C MRS.

Key Words: molecular imaging • MRI • ¹³C • magnetic resonance • spectroscopy

FOOTNOTES

COPYRIGHT © 2008 by the Society of Nuclear Medicine, Inc.

Related articles in JNM:

This Month in JNM

JNM 2008 49: 11A-12A. [Full Text]  

This article has been cited by other articles:

				A. Qayyum MR Spectroscopy of the Liver: Principles and Clinical Applications RadioGraphics, October 1, 2009; 29(6): 1653 - 1664. [Abstract] [Full Text] [PDF]

				W. S. Warren, E. Jenista, R. T. Branca, and X. Chen Increasing Hyperpolarized Spin Lifetimes Through True Singlet Eigenstates Science, March 27, 2009; 323(5922): 1711 - 1714. [Abstract] [Full Text] [PDF]